Obesity is strongly associated with metabolic and cardiovascular disorders. Adiponectin is
an adipose-derived plasma protein that is downregulated in subjects with obesity-related …

Obesity is strongly associated with the pathogenesis of type 2 diabetes, hypertension, and
cardiovascular disease. Levels of the hormone adiponectin are downregulated in obese …

The cardiometabolic syndrome, associated with increased cardiovascular disease risk in the
industrialized world, is estimated to affect one in four adults. Although the mechanisms …

Adiponectin is an abundant plasma protein secreted from adipocytes. Its role in energy
homeostasis is well-known, including the regulation of hydrocarbons and lipids metabolism …

Studies performed during the last decade indicate that adipose tissue is not only a site of
triglyceride storage but also an active endocrine organ which secretes many biologically …

Cardiovascular disease (CVD) is a common disease that seriously threatens the health of
human beings, especially middle-aged and elderly people over 50 years old. It has the …

Metabolic cardiovascular diseases have become a global health concern, and some of their
risk factors are linked to several metabolic disorders. They are the leading causes of death …

The increasing prevalence of diabetes and its complications heralds an alarming situation
worldwide. Obesity-associated changes in circulating adiponectin concentrations have the …

Adiponectin is an adipokine whose biosynthesis is deranged in obesity and diabetes
mellitus, predisposing to atherosclerosis. Evidence suggests that adiponectin has anti …

Adipose tissue secretes a variety of bioactive molecules, also known as adipocytokines or
adipokines. Obesity, in particular, visceral fat accumulation, is implicated in the dysregulated …